Advertisement

Right Heart Catheterization

  • Jean-Luc Vachiéry
  • Céline Dewachter
Chapter

Abstract

Despite advances in imaging, right-heart catheterization (RHC), also called pulmonary artery catheterization, is the gold standard for the assessment of the pulmonary circulation and the right ventricle in healthy and disease states. RHC is mandatory to establish the diagnosis of pulmonary hypertension (PH), to assess disease severity, and to determine prognosis and response to therapy. In addition, it remains a critical tool in the assessment of patients who are candidates for heart transplantation and may be considered in various cardiac disorders. Contrary to popular belief, the procedure is rather safe, even in advanced cases. A recent retrospective and prospective multicenter study reported a procedure-related mortality of 0.055% and morbidity of 1.1% in specialized centers of PH. RHC is a technically demanding procedure that requires meticulous attention to detail and accuracy in interpretation to obtain clinically useful information. It must always be integrated in the general assessment of a patient’s condition, which includes the clinical context and imaging, in particular echocardiography. To obtain high-quality results and minimize the risk of complication, physicians appropriately trained in handling and interpretation of the test should perform the procedure in expert centers.

Keywords

Right-heart catheterization Pulmonary circulation Pulmonary hypertension Hemodynamic Pulmonary artery fluid catheter Zero leveling Pulmonary artery pressure Pulmonary artery wedge pressure 

References

  1. 1.
    Galie N, Humbert M, Vachiery JL, Gibbs S, Lang I, Torbicki A, Simonneau G, Peacock A, Vonk Noordegraaf A, Beghetti M, Ghofrani A, Gomez Sanchez MA, Hansmann G, Klepetko W, Lancellotti P, Matucci M, McDonagh T, Pierard LA, Trindade PT, Zompatori M, Hoeper M. 2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: The Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS): Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT). Eur Respir J. 2015;46:903–75.CrossRefPubMedGoogle Scholar
  2. 2.
    Galie N, Humbert M, Vachiery JL, Gibbs S, Lang I, Torbicki A, Simonneau G, Peacock A, Vonk Noordegraaf A, Beghetti M, Ghofrani A, Gomez Sanchez MA, Hansmann G, Klepetko W, Lancellotti P, Matucci M, McDonagh T, Pierard LA, Trindade PT, Zompatori M, Hoeper M, Aboyans V, Vaz Carneiro A, Achenbach S, Agewall S, Allanore Y, Asteggiano R, Paolo Badano L, Albert Barbera J, Bouvaist H, Bueno H, Byrne RA, Carerj S, Castro G, Erol C, Falk V, Funck-Brentano C, Gorenflo M, Granton J, Iung B, Kiely DG, Kirchhof P, Kjellstrom B, Landmesser U, Lekakis J, Lionis C, Lip GY, Orfanos SE, Park MH, Piepoli MF, Ponikowski P, Revel MP, Rigau D, Rosenkranz S, Voller H, Luis Zamorano J. 2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: The Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS): Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT). Eur Heart J. 2016;37:67–119.CrossRefPubMedGoogle Scholar
  3. 3.
    McMurray JJ, Adamopoulos S, Anker SD, Auricchio A, Bohm M, Dickstein K, Falk V, Filippatos G, Fonseca C, Gomez-Sanchez MA, Jaarsma T, Kober L, Lip GY, Maggioni AP, Parkhomenko A, Pieske BM, Popescu BA, Ronnevik PK, Rutten FH, Schwitter J, Seferovic P, Stepinska J, Trindade PT, Voors AA, Zannad F, Zeiher A. Esc guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: the task force for the diagnosis and treatment of acute and chronic heart failure 2012 of the european society of cardiology. Developed in collaboration with the heart failure association (hfa) of the esc. Eur Heart J. 2012;33:1787–847.CrossRefGoogle Scholar
  4. 4.
    Hoeper MM, Lee SH, Voswinckel R, Palazzini M, Jais X, Marinelli A, Barst RJ, Ghofrani HA, Jing ZC, Opitz C, Seyfarth HJ, Halank M, McLaughlin V, Oudiz RJ, Ewert R, Wilkens H, Kluge S, Bremer HC, Baroke E, Rubin LJ. Complications of right heart catheterization procedures in patients with pulmonary hypertension in experienced centers. J Am Coll Cardiol. 2006;48:2546–52.CrossRefPubMedGoogle Scholar
  5. 5.
    Naeije R, Vachiery JL, Yerly P, Vanderpool R. The transpulmonary pressure gradient for the diagnosis of pulmonary vascular disease. Eur Respir J. 2013;41:217–23.CrossRefPubMedGoogle Scholar
  6. 6.
    Tedford RJ, Beaty CA, Mathai SC, Kolb TM, Damico R, Hassoun PM, Leary PJ, Kass DA, Shah AS. Prognostic value of the pre-transplant diastolic pulmonary artery pressure-to-pulmonary capillary wedge pressure gradient in cardiac transplant recipients with pulmonary hypertension. J Heart Lung Transplant. 2014;33:289–97.CrossRefPubMedGoogle Scholar
  7. 7.
    Hoeper MM, Bogaard HJ, Condliffe R, Frantz R, Khanna D, Kurzyna M, Langleben D, Manes A, Satoh T, Torres F, Wilkins MR, Badesch DB. Definitions and diagnosis of pulmonary hypertension. J Am Coll Cardiol. 2013;62:D42–50.CrossRefPubMedGoogle Scholar
  8. 8.
    Kovacs G, Berghold A, Scheidl S, Olschewski H. Pulmonary arterial pressure during rest and exercise in healthy subjects: a systematic review. Eur Respir J. 2009;34:888–94.CrossRefPubMedGoogle Scholar
  9. 9.
    D’Alto M, Romeo E, Argiento P, Motoji Y, Correra A, Di Marco GM, Mattera Iacono A, Barracano R, D'Andrea A, Rea G, Sarubbi B, Russo MG, Naeije R. Clinical relevance of fluid challenge in patients evaluated for pulmonary hypertension. Chest. 2017;151(1):119–26.CrossRefPubMedGoogle Scholar
  10. 10.
    Andersen MJ, Olson TP, Melenovsky V, Kane GC, Borlaug BA. Differential hemodynamic effects of exercise and volume expansion in people with and without heart failure. Circ Heart Fail. 2015;8:41–8.CrossRefPubMedGoogle Scholar
  11. 11.
    Fujimoto N, Borlaug BA, Lewis GD, Hastings JL, Shafer KM, Bhella PS, Carrick-Ranson G, Levine BD. Hemodynamic responses to rapid saline loading: the impact of age, sex, and heart failure. Circulation. 2013;127:55–62.CrossRefPubMedGoogle Scholar
  12. 12.
    Borlaug BA, Nishimura RA, Sorajja P, Lam CS, Redfield MM. Exercise hemodynamics enhance diagnosis of early heart failure with preserved ejection fraction. Circ Heart Fail. 2010;3:588–95.CrossRefPubMedPubMedCentralGoogle Scholar
  13. 13.
    Hager WD, Collins I, Tate JP, Azrin M, Foley R, Lakshminarayanan S, Rothfield NF. Exercise during cardiac catheterization distinguishes between pulmonary and left ventricular causes of dyspnea in systemic sclerosis patients. Clin Respir J. 2013;7:227–36.CrossRefPubMedGoogle Scholar
  14. 14.
    Herve P, Lau EM, Sitbon O, Savale L, Montani D, Godinas L, Lador F, Jais X, Parent F, Gunther S, Humbert M, Simonneau G, Chemla D. Criteria for diagnosis of exercise pulmonary hypertension. Eur Respir J. 2015;46:728–37.CrossRefPubMedGoogle Scholar
  15. 15.
    Rosenkranz S, Gibbs JS, Wachter R, De Marco T, Vonk-Noordegraaf A, Vachiery JL. Left ventricular heart failure and pulmonary hypertension. Eur Heart J. 2016;37:942–54.CrossRefPubMedGoogle Scholar
  16. 16.
    Mehta S, Vachiery JL. Frontiers in clinical practice: pulmonary hypertension – the importance of correctly diagnosing the cause. Eur Respir Rev. 2016;25(142):372–80.CrossRefPubMedGoogle Scholar

Copyright information

© Springer International Publishing AG, part of Springer Nature 2018

Authors and Affiliations

  1. 1.Department of Cardiology, Pulmonary Vascular Diseases and Heart Failure ClinicCUB—Erasme University HospitalBrusselsBelgium

Personalised recommendations